World Health Organization. The Global Burden of Disease: 2004 Update. WHO, 2008.
Dimidjian, S, Barrera, M Jr, Martell, C, Muñoz, RF, Lewinsohn, PM.
The origins and current status of behavioural activation treatments for depression. Annu Rev Clin Psychol
2011; 7: 1–38.
Kanter, JW, Manos, RC, Bowe, WM, Baruch, DE, Busch, AM, Rusch, LC.
What is behavioural activation? A review of the empirical literature. Clin Psychol Rev
2010; 30: 608–20.
Jacobson, NS, Dobson, KS, Truax, PA, Addis, ME, Koerner, K, Gollan, JK, et al.
A component analysis of cognitive behavioural treatment for depression. J Consult Clin Psychol
1996; 64: 295–304.
Mazzucchelli, T, Kane, R, Rees, C.
Behavioural activation treatments for depression in adults: a meta-analysis and review. Clin Psychol Sci Pract
2009; 16: 383–411.
Dimidjian, S, Hollon, SD, Dobson, KS, Schmaling, KB, Kohlenberg, RJ, Addis, ME, et al.
Randomized trial of behavioural activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol
2006; 74: 658–70.
Ekers, D, Godfrey, C, Gilbody, S, Parrott, S, Richards, DA, Hammond, D, et al.
Cost utility of behavioural activation delivered by the non-specialist. Br J Psychiatry
2011; 199: 510–1.
Manos, RC, Kanter, JW, Busch, AM.
A critical review of assessment strategies to measure the behavioural activation model of depression. Clin Psychol Rev
2010; 30: 547–61.
Dichter, GS, Felder, JN, Petty, C, Bizzell, J, Ernst, M, Smoski, MJ.
The effects of psychotherapy on neural responses to rewards in major depression. Biol Psychiatry
2009; 66: 886–97.
Rusch, LC, Kanter, JW, Brondino, MJ, Weeks, CE, Bowe, WM.
Biomedical stigma reduction programs produce negative but transient effects on a depressed low-income community sample. J Soc Clin Psychol
2010; 29: 1021–31.